Oenon Holdings, Inc. engages in alcoholic beverages, food products, enzymes and pharmaceuticals, real estate, bioethanol, and other businesses in Japan and internationally. The company offers alcoholic beverages, including Shochu, chu-hi, sake, sake compounds, umeshu plum wine, processed liquor, wine, brewing and industrial alcohol, seasonings, and other products. It also provides enzymes for food and industrial use comprising lactase, a lactose hydrolytic enzyme; cellulase, a dietary fiber processing enzyme; glucose isomelase, a fructose syrup manufacturing enzyme; and dispase, a cell dispersion enzyme. In addition, the company provides active pharmaceutical ingredients, such as pravastatin for hyperlipidemia treatment; and voglibose for diabetes mellitus treatment. Further, it provides diagnostic products comprising fecal occult blood test reagents for screening colon cancer; salivary occult blood test reagents for screening periodontal disease; and urological test reagents. Additionally, the company offers health food ingredients, such as Agaricus blazei and L-arabinose; and starch for food processing. It also engages in the purchase and sale, rental, and maintenance of real estate properties; management of restaurants; and the provision of bioethanol and distiller's dried grains with solubles, as well as warehousing and logistics services. Oenon Holdings, Inc. was founded in 1924 and is headquartered in Tokyo, Japan.
oenon holdings inc (2533:Tokyo)
|No competitor information is available for 2533.|
|View Industry Companies|
Sponsored Financial Commentaries
To contact OENON HOLDINGS INC, please visit www.oenon.jp. Company data is provided by Capital IQ. Please use this form to report any data issues.